“…Polk is unique since it exists in the three biological domains, i.e., Eukarya, Archaea, and Bacteria, while other specialized Pols are present either in Eukarya or Bacterial/Archaea [Gerlach et al, 1999;Ogi et al, 1999;Wagner et al, 1999;Gruz et al, 2001]. Polk has been shown to bypass a variety of structurally unrelated DNA lesions such as N 2 -guanine adducts by benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide (BPDE) [Ogi et al, 2002;Suzuki et al, 2002;Huang et al, 2003;Avkin et al, 2004;Niimi et al, 2009;Sassa et al, 2011Sassa et al, , 2014Jha et al, 2016], 2-acetylaminofluorene [Zhang et al, 2000], methylglyoxal [Yuan et al, 2011], and monoalkylating agents [Choi et al, 2006], a C8-guanine adduct by 2amino-1-methyl-6-phenylimidazo[4,5-b]pyrimidine (PhIP) [Fukuda et al, 2009], thymine glycol [Fischhaber et al, 2002;Yoon et al, 2010], 8-oxoguanine [Zhang et al, 2000;Haracska et al, 2002;Jaloszynski et al, 2005], and interstrand cross-links [Minko et al, 2008;Takeiri et al, 2014;Kanemaru et al, 2017]. Besides TLS, Polk appears to be involved in nucleotide excision repair [Ogi et al, 2010], replication checkpoint [Betous et al, 2013], DNA synthesis through non-B structures [Betous et al, 2009], and repair of strand breaks in DNA [Zhang et al, 2013].…”